This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Yen EF, Kane SV, Ladabaum U.Cost-effectiveness of mesalamine (5-aminosalicyclic acid, 5-ASA) therapy for maintenance of remission in ulcerative colitis. Gastroenterology 130 (Suppl. 2): 619 (plus poster) abstr. W1028, No. 4, Apr 2006
Rights and permissions
About this article
Cite this article
Mesalazine effective in ulcerative colitis, but at cost. Pharmacoecon. Outcomes News 508, 8 (2006). https://doi.org/10.2165/00151234-200605080-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605080-00022